(株)中京医薬品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4558/E03289 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/03/31 | 日証協 | 485,900株 | -0.16% | 54,500株 | +2080% | 494,888株 | -48.37% | 494,621株 | +8427.95% |
2023/03/24 | 日証協 | 486,700株 | -3.26% | 2,500株 | -41.86% | 958,439株 | -0.16% | 5,800株 | -61.07% |
2023/03/17 | 日証協 | 503,100株 | +0.46% | 4,300株 | +4200% | 959,939株 | -2.53% | 14,900株 | -10.25% |
2023/03/10 | 日証協 | 500,800株 | -2.83% | 100株 | -98.96% | 984,838株 | -1.14% | 16,601株 | +0.49% |
2023/03/03 | 日証協 | 515,400株 | +2.42% | 9,600株 | -79.96% | 996,238株 | +1.2% | 16,520株 | -30% |
2023/02/24 | 日証協 | 503,200株 | +0.58% | 47,900株 | +1194.59% | 984,418株 | -0.3% | 23,600株 | +112.54% |
2023/02/17 | 日証協 | 500,300株 | -4.7% | 3,700株 | -90.24% | 987,418株 | -2.21% | 11,104株 | -75.61% |
2023/02/10 | 日証協 | 525,000株 | +3.2% | 37,900株 | +18.44% | 1,009,713株 | +2.55% | 45,522株 | +104.13% |
2023/02/03 | 日証協 | 508,700株 | +1.15% | 32,000株 | +150% | 984,596株 | +0.11% | 22,300株 | +13.78% |
2023/01/27 | 日証協 | 502,900株 | -4.7% | 12,800株 | -28.09% | 983,496株 | -1.05% | 19,600株 | -25.77% |
2023/01/20 | 日証協 | 527,700株 | -7.74% | 17,800株 | -74.68% | 993,896株 | -2.41% | 26,404株 | -41.98% |
2023/01/13 | 日証協 | 572,000株 | +3.53% | 70,300株 | +453.54% | 1,018,392株 | +0.72% | 45,505株 | +540.55% |
2023/01/06 | 日証協 | 552,500株 | -3.53% | 12,700株 | -52.79% | 1,011,091株 | -1.03% | 7,104株 | -82.8% |
2022/12/30 | 日証協 | 572,700株 | +3.3% | 26,900株 | +73.55% | 1,021,591株 | -6.29% | 41,300株 | +100.38% |
2022/12/23 | 日証協 | 554,400株 | +1.24% | 15,500株 | +109.46% | 1,090,185株 | +0.07% | 20,611株 | +53.81% |
2022/12/16 | 日証協 | 547,600株 | +1.03% | 7,400株 | -58.89% | 1,089,385株 | +0.3% | 13,400株 | -28.72% |
2022/12/09 | 日証協 | 542,000株 | +0.74% | 18,000株 | +1400% | 1,086,085株 | +0.29% | 18,800株 | +203.23% |
2022/12/02 | 日証協 | 538,000株 | -0.92% | 1,200株 | -83.1% | 1,082,985株 | +1.04% | 6,200株 | -68.53% |
2022/11/18 | 日証協 | 541,000株 | +0.02% | 33,100株 | -47.87% | 1,068,884株 | +0.59% | 39,700株 | -32.02% |
※株式分割は考慮していませんのでご注意ください。
Page Top